Effects of losartan and captopril on endothelin-1 production in blood vessels and glomeruli of rats with reduced renal mass

American Journal of Hypertension

Volumn 11, Issue 8 I, 1998, Pages 989-997

  Larivière, Richard ^a,b   Lebel, Marcel ^a,b   Kingma, Iris ^a,b   Grose, John H ^a,b   Boucher, Daniel ^a,b  

^a LAVAL UNIVERSITY   (Canada)

^b UNIVERSITÉ LAVAL   (Canada)

Author keywords

Angiotensin II; Blood vessels; Captopril; Chronic renal failure; Endothelin 1; Glomeruli; Hypertension; Losartan

Indexed keywords

CAPTOPRIL; ENDOTHELIN 1; LOSARTAN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BLOOD PRESSURE REGULATION; CHRONIC KIDNEY FAILURE; CONTROLLED STUDY; GLOMERULUS; HORMONE RELEASE; HYPERTENSION; MALE; MESENTERIC ARTERY; NONHUMAN; ORAL DRUG ADMINISTRATION; PRIORITY JOURNAL; RAT; THORACIC AORTA;

ANGIOTENSIN II; ANIMALS; BLOOD PRESSURE; BLOOD VESSELS; CAPTOPRIL; ENDOTHELIN-1; KIDNEY FAILURE, CHRONIC; KIDNEY GLOMERULUS; LOSARTAN; MALE; NEPHRECTOMY; RATS; RATS, SPRAGUE-DAWLEY;

EID: 0344111148     PISSN: 08957061     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0895-7061(98)00088-0     Document Type: Article

References (46)

1. Jacobson HR: Chronic renal failure: pathophysiology. Lancet 1991;338:419-423.
2. Brown MA, Whitworth JA: Hypertension in human renal disease. J Hypertens 1992;10:701-712.
3. Yanagisawa M, Kurihara H, Kimura S, et al: A novel potent vasoconstrictor peptide produced by vascular endothelial cells. Nature 1988;332:411-415.
4. Koyama H, Nishzawa Y, Morii H, et al: Plasma endothelin levels in patients with uremia. Lancet 1989;991-992.
5. Lebel M, Grose JH, Kingma I, Langlois S: Plasma endothelin levels and blood pressure in hemodialysis and in CAPD patients: effect of subcutaneous erythropoietin replacement therapy. Clin Exp Hypertens 1994;16: 565-575.
6. Orisio S, Benigni A, Bruzzi I, et al: Renal endothelin gene expression is increased in remnant kidney and correlates with disease progression. Kidney Intern 1993;43:354-358.
7. Brooks DP, Contino LC, Storer B, Ohlstein EH: Increased endothelin excretion in rats with renal failure induced by partial nephrectomy. Br J Pharmacol 1991; 104:987-989.
8. Larivière R, D'Amours M, Lebel M, et al: Increased immunoreactive endothelin-1 in blood vessels and glomeruli of rats with reduced renal mass. Kidney Blood Pressure Res 1997;20:372-380.
9. Katoh T, Chang H, Uchida S, et al: Direct effects of endothelin in the rat kidney. Am J Physiol 1990;258: 397-403.
10. + exchange, c-fos expression, and mitogenesis in rat mesangial cells. J Clin Invest 1989;83:708-712.
11. Gómez-Garre D, Ruíz-Ortega M, Ortego M, et al: Effects and interactions of endothelin-1 and angiotensin II on matrix protein expression and synthesis and mesangial cell growth. Hypertension 1996;27:885-892.
12. Emori T, Hirata Y, Ohta K, et al: Secretory mechanism of immunonative endothelin in cultured bovine endothelial cells. Biochem Biophys Res Commun 1989;160: 93-100.
13. Kohno M, Horio T, Ideka M, et al: Angiotensin II stimulates endothelin-1 secretion in cultured rat mesangial cells. Kidney Intern 1992;42:860-866.
14. Abassi ZA, Klein H, Golomb E, Keiser HR: Regulation of the urinary excretion of endothelin in the rat. Am J Hypertens 1993;6:453-457.
15. Chen L, McNeill JR, Wilson TW, Gopalakrishnan V: Heterogeneity in vascular smooth muscle responsiveness to angiotensin II: role of endothelin. Hypertension 1995;26:83-88.
16. Balakrishnan SM, Wang HD, Gopalakrishnan V, et al: Effect of an endothelin antagonist on hemodynamic responses to angiotensin II. Hypertension 1996;28:806-809.
17. Bakris GL, Re RN: Endothelin modulates angiotensin II-induced mitogenesis of human mesangial cells. Am J Physiol 1993;264:F937-F942.
18. Anderson S, Rennke HG, Brenner BM: Therapeutic advantage of converting enzyme inhibitors in arresting progressive renal disease associated with systemic hypertension in the rat. J Clin Invest 1986;77:1993-2000.
19. Lafayette RA, Mayer G, Park SK, Meyer TW: Angiotensin II receptor blockade limits glomerular injury in rats with reduced renal mass. J Clin Invest 1992;90:766-771.
20. Benigni A, Zoja C, Corna D, et al: A specific endothelin subtype A receptor antagonist protects against injury in renal disease progression. Kidney Intern 1993;44:440-444.
21. Kakinuma Y, Kawamura T, Bills T, et al: Blood pressure-independent effect of angiotensin inhibition on vascular lesions of chronic renal failure. Kidney Intern 1992;42:46-55.
22. De Leon H, Garcia R: Angiotensin II receptor subtypes in rat renal preglomerular vessels. Receptor 1992;2:253-260.
23. De Leon H, Garcia R: Regulation of glomerular atrial natriuretic factor receptor subtypes by renal sympathetic nerves. Am J Physiol 1991;260:R1043-R1050.
24. Larivière R, Thibault G, Schiffrin EL: Increased endothelin content in blood vessels of deoxycorticosterone acetate-salt hypertensive but not of spontaneously hypertensive rats. Hypertension 1993;21:294-300.
25. Day R, Larivière R, Schiffrin EL: In situ hybridization shows increased endothelin-1 mRNA in endothelial cells of blood vessels of deoxycorticosterone acetate-salt hypertensive rats. Am J Hypertens 1995;8:294-300.
26. Wagner OF, Christ G, Wojta J, et al: Polar secretion of endothelin-1 by cultured endothelial cells. J Biol Chem 1992;267:16066-16068.
27. Marsden PA, Dorfman DM, Collins T, et al: Regulated expression of endothelin-1 in glomerular capillary endothelial cells. Am J Physiol 1991;261:F117-F125.
28. Wilkes BM, Susan M, Mento PF, et al: Localization of endothelin like immunoreactivity in rat kidneys. Am J Physiol 1991;260:F913-F920.
29. Rosenberg ME, Smith LJ, Correa-Rotter R, Hostetter TH: The paradox of the renin-angiotensin system in chronic renal disease. Kidney Intern 1994;45:403-410.
30. Kuczera M, Hilgers KF, Lisson C, et al: Local angiotensin formation in hindlimbs of uremic hypertensive and renovascular hypertensive rats. J Hypertens 1991;9:41-48.
31. Correa-Rotter R, Hostetter TH, Manivel C, Rosenberg ME: Renin expression in renal ablation. Hypertension 1992;20:483-490.
32. Rosenberg ME, Correa-Rotter R, Inagami T, et al: Glomerular renin synthesis and storage in the remnant kidney. Kidney Intern 1991;40:677-683.
33. Ashab I, Peer G, Blum M, et al: Oral administraiton of L-arginine and captopril in rats prevents chronic renal failure by nitric oxide production. Kidney Intern 1995; 47:1515-1521.
34. De Nucci G, Thomas R, D'Orléans-Juste P, et al: Pressor effects of circulating endothelin are limited by its removal in the pulmonary circulation and by the release of prostacyclin and endothelium-derived relaxing factor. Proc Natl Acad Sci USA 1988;85:9797-9800.
35. Ito S, Johnson CS, Carretero OA: Modulation of angiotensin II-induced vasoconstriction by endothelin-derived relaxing factor in the isolated microperfused rabbit afferent arteriole. J Clin Invest 1991;87:1656-1663.
36. Ito S, Juncos LA, Nushiro N, et al: Endothelium-derived relaxing factor modulates endothelin action in afferent arterioles. Hypertension 1991;17:1052-1056.
37. Mathana J, Singhal PC: L-arginine supplementation antagonizes the effects of angiotensin II and endothelin I on mesangial cell proliferation. Cell Physiol Biochem 1995;5:176-192.
38. Yoshizumi M, Kurihara H, Sugiyama T, et al: Hemodynamic shear stress stimulates endothelin production by cultured endothelial cells. Biochem Biophys Res Commun 1989;161:859-864.
39. Momose N, Fukuo K, Morimoto S, Ogihara T: Captopril inhibits endothelin-1 secretion from endothelial cells through bradykinin. Hypertension 1993;21:921-924.
40. Li JS, Larivière R, Schiffrin EL: Effect of a non selective endothelin antagonist on vascular remodeling in deoxycorticosterone acetate-salt hypertensive rats: evidence for a role of endothelin in vascular hypertrophy. Hypertension 1994;24:183-188.
41. Schiffrin EL, Larivière R, Li JS, Sventek P: Enhanced expression of the endothelin-1 gene in blood vessels of DOCA-salt hypertensive rats: correlation with vascular structure. J Vasc Res 1996;33:235-248.
42. Fukuda K, Yanagida T, Okuda S, et al: Role of endothelin as a mitogen in experimental glomerulonephritis in rats. Kidney Intern 1996;49:1320-1329.
43. 2 analogue. Lab Invest 1991;64:16-20.
44. Junaid A, Rosenberg ME, Hostetter TH: Interaction of angiotensin II (AII) and transforming growth factor beta (TGF-β) in the remnant kidney. J Am Soc Nephrol 1993;4:772(93P).
45. Benigni A, Perico N, Gaspari F, et al: Increased renal endothelin production in rats with reduced renal mass. Am J Physiol 1991;260:F331-F339.
46. Abassi ZA, Tate JE, Golomb E, Keiser HR: Role of neutral endopeptidase in the metabolism of endothelin. Hypertension 1992;20:89-95.